Leading experts in immunology, immuno-oncology and cancer cell therapies bring their expertise to advance development and clinical goals of companyDublin, Ireland, May 25, 2022 – RemedyBio, a biotech company pioneering its proprietary ultra-high throughput single cell Nanoreactor™ platform for discovery and developm.
SV Health Investors Joins Prilenia Series B as the Company Prepares for ALS and HD Data Readouts in the Next 12 Months - read this article along with other careers information, tips and advice on BioSpace
A future vaccine providing protection against a wide range of coronaviruses that jump from their original animal hosts to humans -; including SARS-CoV-2, the cause of COVID-19 -; may be possible, say Johns Hopkins Medicine researchers, based on findings from their recent study.